The CBD present in oils and other products is usually derived from fiber-type varieties of cannabis (hemp), because these are naturally higher in CBD content than drug-type varieties (marijuana). Although cultivation of hemp is allowed in many countries around the world, this is usually governed by strict regulations. After being banned for decades, hemp cultivation in the USA has only recently been reintroduced, and is still gearing up for full industrial production .
For pain management, both topical and oral CBD work well, typically proving the most effective relief when utilized together. Oral CBD also assists in the diminishing of symptoms from anxiety, depression and other mental disorders, as well as insomnia. Topicals work brilliantly at reducing inflammation, arthritis, headaches, cramping and migraines, and some evidence has shown that it can also heal eczema, psoriasis, dermatitis and itching.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.